Pfizer Inc. (NYSE:PFE) is included among the 13 Best Dividend Stocks Paying Over 6%. On January 7, UBS initiated coverage of Pfizer Inc. (NYSE:PFE) with a Neutral rating and a $25 price target. The ...

Tempus AI stock contract value exceeds $1.1B with 70 pharma deals. Diagnostics revenue up 111%, data segment up 31% in 2025 ...

This makes Pfizer a potentially cheap stock to buy while collecting a solid dividend. It's generated about $14 billion in free cash flow and $10 billion profits over the training 12 months alone. So, ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

There were 1,399 unusually active options in Thursday’s trading. Pfizer’s March 20 $29 put had the highest Vol/OI ratio at ...

Pfizer ( PFE +0.24%) pays a dividend that yields around 6.8%. While the yield has been pushed higher as share prices have delivered a lackluster performance at best in the last few years, Pfizer has a ...

Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the big leagues.

Pfizer shares are trading in the mid-$20s as investors grapple with a critical question: is this battered pharmaceutical giant destined to remain stuck in neutral, or does its aggressive push into ...

Tempus AI stock remains in a bear market after crashing by 36% from its highest point in September last year. What next for ...

Jim Cramer has built a strong reputation in the industry. He’s the Mad Money host who carefully picks growth stocks that have ...

AbbVie's Q1 2026 dividend increases 5.5% YOY, lagging both its past growth rates and the healthcare sector median. Learn more ...

As of Friday, January 09, Allogene Therapeutics, Inc.’s ALLO share price has surged by 18.13%, which has investors ...